FIELD: medicine.
SUBSTANCE: therapeutically effective amount of a recombinant plasmid with a nucleotide sequence of SEQ ID NO:1, which contains a modified nucleotide sequence coding human BDNF, and the Kozak consensus sequence, is introduced into an involved muscle; pVax1 Invitrogen is used as a plasmid vector.
EFFECT: invention discloses an effective method to accelerate the restoration of the structure and conductivity of peripheral nerves after an injury, by transfection of the muscles innervated by the injured nerve, by means of a new plasmid construct coding the brain-derived neurotrophic factor.
3 cl, 5 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STIMULATING RECOVERY OF DAMAGED TISSUE INNERVATION | 2014 |
|
RU2563541C1 |
| METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION | 2011 |
|
RU2486918C1 |
| GENETIC ENGINEERING STRUCTURE FOR STIMULATING POST-TRAUMATIC REGENERATION OF PERIPHERAL NERVES | 2019 |
|
RU2719013C1 |
| CODON-OPTIMISED RECOMBINANT PLASMID, STIMULATION TECHNIQUE FOR PERIPHERAL NERVE REGENERATION, TREATMENT MODALITY FOR DAMAGED HUMAN NERVE | 2014 |
|
RU2558294C1 |
| METHOD FOR INDUCTION OF PERIPHERAL NERVE REGENERATION | 2016 |
|
RU2639175C1 |
| METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
| METHOD FOR SIMULATING ANGIOGENESIS, TREATING NEUROGENERATIVE DISEASES AND REGENERATING SKELETAL MUSCLE USING PLASMID CONSTRUCTS WITH GENES FOR ANGIOGENIC AND NEUROTROPHIC FACTORS | 2020 |
|
RU2805082C2 |
| METHOD FOR STIMULATING NEUROTISATION USING NANOSTRUCTURED MATRIX AND GENETIC CONSTRUCTS | 2012 |
|
RU2517117C2 |
| GENETIC CONSTRUCT CONTAINING hGDNF CONTROLLED BY TEMPERATURE-SENSITIVE PROMOTOR FOR REGULATED NEUROTROPHIC FACTOR EXPRESSION IN MAMMALIAN CELLS AND BODIES DIRECTLY | 2012 |
|
RU2527169C2 |
| METHOD OF PRODUCING MAMMAL EMBRYONIC STEM CELLS MODIFIED WITH HUMAN NERVE GROWTH FACTOR GENE | 2011 |
|
RU2458984C1 |
